Back to COGT
EMERALD ADVISERS, LLC COGT Position History
Cogent Biosciences, Inc. • Healthcare
Quarters held
4
Latest value
$51.7M
Q3 2026
Peak value
$62M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $56.2M |
| Q1 2026 | $61.1M |
| Q2 2026 | $62M |
| Q3 2026 | $51.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $51.7M | 1.61M | — | — |
| Q2 2026 | $62M | 1.60M | — | — |
| Q1 2026 | $61.1M | 1.59M | — | — |
| Q4 2025 | $56.2M | 1.58M | — | — |
Other funds holding COGT
$868.7M
$808M
$756M
$706.8M